Standard
Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates. / Lameijer, Marnix; Binderup, Tina; Van Leent, Mandy M. T.; Senders, Max L.; Fay, Francois; Malkus, Joost; Sanchez-gaytan, Brenda L.; Teunissen, Abraham J. P.; Karakatsanis, Nicolas; Robson, Philip; Zhou, Xianxiao; Ye, Yuxiang; Wojtkiewicz, Gregory; Tang, Jun; Seijkens, Tom T. P.; Kroon, Jeffrey; Stroes, Erik S. G.; Kjaer, Andreas; Ochando, Jordi; Reiner, Thomas; Pérez-medina, Carlos; Calcagno, Claudia; Fisher, Edward A.; Zhang, Bin; Temel, Ryan E.; Swirski, Filip K.; Nahrendorf, Matthias; Fayad, Zahi A.; Lutgens, Esther; Mulder, Willem J. M.; Duivenvoorden, Raphaël.
In:
Nature Biomedical Engineering, Vol. 2, 2018, p. 279-292.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Lameijer, M, Binderup, T, Van Leent, MMT, Senders, ML, Fay, F, Malkus, J, Sanchez-gaytan, BL, Teunissen, AJP, Karakatsanis, N, Robson, P, Zhou, X, Ye, Y, Wojtkiewicz, G, Tang, J, Seijkens, TTP, Kroon, J, Stroes, ESG
, Kjaer, A, Ochando, J, Reiner, T, Pérez-medina, C, Calcagno, C, Fisher, EA, Zhang, B, Temel, RE, Swirski, FK, Nahrendorf, M, Fayad, ZA, Lutgens, E, Mulder, WJM & Duivenvoorden, R 2018, '
Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates',
Nature Biomedical Engineering, vol. 2, pp. 279-292.
https://doi.org/10.1038/s41551-018-0221-2APA
Lameijer, M., Binderup, T., Van Leent, M. M. T., Senders, M. L., Fay, F., Malkus, J., Sanchez-gaytan, B. L., Teunissen, A. J. P., Karakatsanis, N., Robson, P., Zhou, X., Ye, Y., Wojtkiewicz, G., Tang, J., Seijkens, T. T. P., Kroon, J., Stroes, E. S. G.
, Kjaer, A., Ochando, J., ... Duivenvoorden, R. (2018).
Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.
Nature Biomedical Engineering,
2, 279-292.
https://doi.org/10.1038/s41551-018-0221-2Vancouver
Lameijer M, Binderup T, Van Leent MMT, Senders ML, Fay F, Malkus J et al.
Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.
Nature Biomedical Engineering. 2018;2:279-292.
https://doi.org/10.1038/s41551-018-0221-2Author
Lameijer, Marnix ; Binderup, Tina ; Van Leent, Mandy M. T. ; Senders, Max L. ; Fay, Francois ; Malkus, Joost ; Sanchez-gaytan, Brenda L. ; Teunissen, Abraham J. P. ; Karakatsanis, Nicolas ; Robson, Philip ; Zhou, Xianxiao ; Ye, Yuxiang ; Wojtkiewicz, Gregory ; Tang, Jun ; Seijkens, Tom T. P. ; Kroon, Jeffrey ; Stroes, Erik S. G. ; Kjaer, Andreas ; Ochando, Jordi ; Reiner, Thomas ; Pérez-medina, Carlos ; Calcagno, Claudia ; Fisher, Edward A. ; Zhang, Bin ; Temel, Ryan E. ; Swirski, Filip K. ; Nahrendorf, Matthias ; Fayad, Zahi A. ; Lutgens, Esther ; Mulder, Willem J. M. ; Duivenvoorden, Raphaël. / Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates. In: Nature Biomedical Engineering. 2018 ; Vol. 2. pp. 279-292.
Bibtex
@article{47230acb9f764a7aba7be456f7d0e3a8,
title = "Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates",
author = "Marnix Lameijer and Tina Binderup and {Van Leent}, {Mandy M. T.} and Senders, {Max L.} and Francois Fay and Joost Malkus and Sanchez-gaytan, {Brenda L.} and Teunissen, {Abraham J. P.} and Nicolas Karakatsanis and Philip Robson and Xianxiao Zhou and Yuxiang Ye and Gregory Wojtkiewicz and Jun Tang and Seijkens, {Tom T. P.} and Jeffrey Kroon and Stroes, {Erik S. G.} and Andreas Kjaer and Jordi Ochando and Thomas Reiner and Carlos P{\'e}rez-medina and Claudia Calcagno and Fisher, {Edward A.} and Bin Zhang and Temel, {Ryan E.} and Swirski, {Filip K.} and Matthias Nahrendorf and Fayad, {Zahi A.} and Esther Lutgens and Mulder, {Willem J. M.} and Rapha{\"e}l Duivenvoorden",
note = "Authoe correction: https://www.nature.com/articles/s41551-018-0281-3",
year = "2018",
doi = "10.1038/s41551-018-0221-2",
language = "English",
volume = "2",
pages = "279--292",
journal = "Nature Biomedical Engineering",
issn = "2157-846X",
publisher = "Nature Publishing Group",
}
RIS
TY - JOUR
T1 - Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates
AU - Lameijer, Marnix
AU - Binderup, Tina
AU - Van Leent, Mandy M. T.
AU - Senders, Max L.
AU - Fay, Francois
AU - Malkus, Joost
AU - Sanchez-gaytan, Brenda L.
AU - Teunissen, Abraham J. P.
AU - Karakatsanis, Nicolas
AU - Robson, Philip
AU - Zhou, Xianxiao
AU - Ye, Yuxiang
AU - Wojtkiewicz, Gregory
AU - Tang, Jun
AU - Seijkens, Tom T. P.
AU - Kroon, Jeffrey
AU - Stroes, Erik S. G.
AU - Kjaer, Andreas
AU - Ochando, Jordi
AU - Reiner, Thomas
AU - Pérez-medina, Carlos
AU - Calcagno, Claudia
AU - Fisher, Edward A.
AU - Zhang, Bin
AU - Temel, Ryan E.
AU - Swirski, Filip K.
AU - Nahrendorf, Matthias
AU - Fayad, Zahi A.
AU - Lutgens, Esther
AU - Mulder, Willem J. M.
AU - Duivenvoorden, Raphaël
N1 - Authoe correction: https://www.nature.com/articles/s41551-018-0281-3
PY - 2018
Y1 - 2018
U2 - 10.1038/s41551-018-0221-2
DO - 10.1038/s41551-018-0221-2
M3 - Journal article
C2 - 30936448
VL - 2
SP - 279
EP - 292
JO - Nature Biomedical Engineering
JF - Nature Biomedical Engineering
SN - 2157-846X
ER -
